[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” border_style=”solid”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”no” min_height=”” hover_type=”none” link=””][fusion_text]

Cognitive Enhancement Therapy for Adults with Autism Spectrum Disorder: Results of an 18-month Feasibility Study, Eack, Greenwald, Hogarty, April 2013

Meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Wykes T; Huddy V; Cellard C; McGurk SR; Czobor P, Am J Psychiatry 2011

Summary of Key Research Findings: Cognitive Enhancement Therapy Tri-City Mental Health Services, November, 2011

Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a 2-Year Randomized Trial Shaun M. Eack, Gerard E. Hogarty, Deborah P. Greenwald, Susan S. Hogarty and Matcheri S. Keshavan August 2010

Cognitive enhancement therapy for schizophrenia Harvard Mental Health Letter, October 2010

Neuroprotective Effects of Cognitive Enhancement Therapy Against Gray Matter Loss in Early Schizophrenia Results From a 2-Year Randomized Controlled Trial Shaun M. Eack, PhD; Gerard E. Hogarty, MSW†; Raymond Y. Cho, MD; Konasale M. R. Prasad, MD; Deborah P. Greenwald, PhD; Susan S. Hogarty, MSN; Matcheri S. Keshavan, March Gen Psychiatry/ VOL 67 (NO. 7)  May 3, 2010

One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia Shaun M. Eacka, Deborah P. Greenwald, Susan S. Hogarty, Matcheri S. Keshavan, Schizophrenia Research 120 (2010) 210–216

Brain Changes in Schizophrenia Respond to Non-Drug Therapy John Gever, Senior Editor, MedPage Today, May 03, 2010

New Possibilities in Cognition Enhancement for Schizophrenia Michael F. Green, Ph.D. Am J Psychiatry 166:749-752, July 2009

Cognitive Enhancement Therapy for Early-Course Schizophrenia: Effects of a Two-Year Randomized Controlled Trial Shaun M. Eack, Ph.D. Deborah P. Greenwald, Ph.D. Susan S. Hogarty, M.S.N. Susan J. Cooley, M.N.Ed. Ann Louise DiBarry, M.S.N. Debra M. Montrose, Ph.D. Matcheri S. Keshavan, M.D. Psychiatric Services, November 2009 Vol. 60 No. 11

Benefits of CET Intervention for Schizophrenia Persist at Least 2 Years Norra MacReady, Medscape Medical News, November 25, 2009

Durability and Mechanism of Effects of Cognitive Enhancement Therapy Gerard E. Hogarty, M.S.W.Deborah P. Greenwald, Ph.D. Shaun M. Eack, M.S.W.  Psychiatric Services December 2006 Vol. 57 No. 12

Cognitive enhancement therapy for schizophrenia, effects of a 2-year randomized trial on cognition and behavior. Hogarty, G. E.; Flesher, S.; Ulrich, R.; Carter, M.; Greenwald, D.; & Pogue-Geile, M., Archives of General Psychiatry, 2004, 61, 866-876.

Practice Principles of Cognitive Enhancement Therapy for Schizophrenia Gerard E. Hogarty and Samuel Flesher, Schizophrenia Bulletin, Vol. 25, No. 4, 1999